CERN-MEDICIS : Innovative radioisotopes for medical applications

by Thierry Stora (CERN)

Wednesday 30 Nov 2016, 14:30 → 15:15 Europe/Zurich

26/1-22 (CERN)

A.P. Bernardes¹, R. Catherall¹, K. Kershaw¹, S. Marzari¹, T. Stora¹,J. Prior², L. Buehler³, O. Ratib³

¹CERN, Geneva, Switzerland

²CHUV, Lausanne, Switzerland

³HUG, Geneva, Switerland

Email: Thierry Stora  

Isotope mass Separation OnLine has been developed for over fifty years notably at Isolde to address fundamental questions in nuclear structure and astrophysics. In parallel, applications for solid state physics have benefited from the diversity and purity of the radioactive ion beams available in ISOL facilities, as seen with the large variety of beams and applied research program developed at Isolde. In the past fifteen years, medical applications have also been developed, culminating with the recent construction of a dedicated extension, CERN-MEDICIS, which is expected to start operating next year. Dedicated targets will be irradiated in the beam dump position of the Isolde HRS target station, and radioisotopes fractions will be extracted thanks to a dedicated isotope mass separator. With an access to dedicated isotope batches for medical applications, research projects will be developed in the fields of targeted radiotherapy, surgery, and Pet-aided hadron therapy within a network of medical and fundamental research institutions. This program is stimulated by a starting European Marie Curie training network, MEDICIS-Promed, across fifteen institutes in the H2020 framework program of the European Commission. The latest updates on both the infrastructures, ongoing projects and future aspects of medical applications at CERN will be presented.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 642889.